Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls

The therapeutic paradigm of gliomas is changing from a general approach towards an individualized and targeted approach. Accordingly, the search for prognostic and predictive biomarkers, as well as the demand for quantitative, feasible and robust methods for biomarker analysis increases. We find tha...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:CNS Oncol
Asıl Yazarlar: Dahlrot, Rikke H, Sørensen, Mia D, Rosager, Ann Mari, Hellwege, Sofie, Bangsø, Julie A, Rosenberg, Tine, Petterson, Stine A, Klitkou, Jacob, Fosmark, Sigurd, Hansen, Steinbjørn, Kristensen, Bjarne W
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Future Medicine Ltd 2014
Konular:
Management Perspective
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6124359/
https://ncbi.nlm.nih.gov/pubmed/25286040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns.14.30
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller